Bio-Rad Laboratories has improved its Liquichek quality control product portfolio with the launch of an enhanced version of its Liquichek Opiate Control.
This enhanced version of Liquichek Opiate Control includes updated fentanyl target levels optimized for clinically relevant cutoffs across chemistry major platforms. This ensures laboratories can meet evolving testing requirements with confidence and precision.
Bio-Rad’s Liquichek Opiate Control contains eight opioid drugs or drug metabolites, at concentrations above and below assay cutoffs as recommended by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), other agencies, or reagent manufacturers. The control is tested by GC/MS, LC/MS/MS and other methods to confirm the recovery of drug concentration, with representative values provided for screening and confirmatory methods.
Liquichek Opiate Control is available now. Visit bio-rad.com to learn more about Bio-Rad’s Toxicology quality control portfolio.
